TLSI - TriSalus Life Sciences, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 5.02

Open

$ 4.74

Bid

$ 4.35 x 60

Ask

$ 5.08 x 10

Day's Range

$ 4.67 - $ 5.02

52 Week Range

$ 3.42 - $ 5.88

Volume

212,959

Average Volume

Market Cap

250.33M

Beta (5Y Monthly)

$ 0.32

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	04-15-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	04-11-2024	12-31-2023	10-K
8	11-14-2023	09-30-2023	10-Q
9	08-01-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	03-22-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-10-2022	06-30-2022	10-Q
14	05-11-2022	03-31-2022	10-Q
15	03-02-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	06-28-2021	03-31-2021	10-Q
19	03-31-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

TriSalus Life Sciences FY2025 Revenue exp...
08/12/2025 20:03:23

TriSalus Life Sciences (NASDAQ:TLSI) FY2025 Revenue expected to be more than $44.147M vs $44.837M Est. Revenue for 2025 FY is e...

TriSalus Life Sciences Q2 EPS $(0.27) Miss...
08/12/2025 20:02:01

TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate...

Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

TriSalus Life Sciences Publishes Safety An...
08/11/2025 12:10:59

TriSalus Life Sciences Initiates Exchange ...
06/23/2025 21:35:46

TriSalus Life Sciences Appoints David Pat...
05/30/2025 11:02:34

TriSalus Life Sciences confirming FY 2025 ...
05/15/2025 12:12:38

TriSalus Life Sciences (NASDAQ:TLSI) confirming FY 2025 guidance of at least 50% revenue growth.

TriSalus Life Sciences Q1 EPS $(0.39) Miss...
05/15/2025 11:01:34

TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate...

Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

TriSalus Life Sciences Says Prelim. Q1 Res...
04/30/2025 12:10:54

TriSalus Life Sciences Announces $22M Priv...
04/30/2025 12:08:39

Private PlacementThe private placement is being led by Nantahala Capital and includes investments by Broadfin Holdings and addi...

Canaccord Genuity Maintains Buy on TriSalu...
03/28/2025 15:17:27

Canaccord Genuity analyst William Plovanic maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and maintains $11 price...

TriSalus Reaffirms 2025 Guidance Of Greate...
03/27/2025 11:33:32

TriSalus Life Sciences Q4 2024 GAAP EPS $(...
03/27/2025 11:31:54

TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate...

Earnings Scheduled For March 27, 2025
03/27/2025 08:32:15

Examining the Future: TriSalus Life Scienc...
03/26/2025 17:01:23

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
03/21/2025 21:05:50

Trisalus Life Sciences Entered A $50M, Fiv...
02/19/2025 11:19:50

Lake Street Initiates Coverage On TriSalus...
02/13/2025 23:03:21

Lake Street initiates coverage on TriSalus Life Sciences (NASDAQ:TLSI) with a Buy rating and announces Price Target of $10.

TriSalus Life Sciences Announces $10M Draw...
02/03/2025 13:03:10

TriSalus Life Sciences® Inc. (NASDAQ:TLSI), a biomedical technology company seeking to transform outcomes for patients with sol...